The Discounted Cash Flow (DCF) valuation of Jenburkt Pharmaceuticals Ltd (524731.BO) is 934.93 INR. With the latest stock price at 1,343.95 INR, the upside of Jenburkt Pharmaceuticals Ltd based on DCF is -30.4%.
Based on the latest price of 1,343.95 INR and our DCF valuation, Jenburkt Pharmaceuticals Ltd (524731.BO) is a sell. selling 524731.BO stocks now will result in a potential gain of 30.4%.
| Range | Selected | |
| WACC / Discount Rate | 11.7% - 14.2% | 13.0% |
| Long-term Growth Rate | 2.5% - 4.5% | 3.5% |
| Fair Price | 790.44 - 1,168.56 | 934.93 |
| Upside | -41.2% - -13.1% | -30.4% |